New York, NY -- October 3, 2022 -- InvestorsHub NewsWire
-- via Traders News Source, a leading independent equity
research and corporate access firm focused on small cap growth
companies issues new research.
Simplicity Esports and Gaming Company (OTCQB:
WINR) has entered into an exchange agreement with
Diverted River Technology, LLC, in which Simplicity Esports agreed
to acquire 100% of the membership interests of Diverted River in
exchange for 80% of the issued and outstanding shares of Simplicity
Esports’ common stock. It is expected that, Simplicity Esports’
name will be changed to Diverted River Technology, Inc., and the
business of Simplicity Esports will become that of Diverted River,
an ETO focused on a sustainable, high margin, recurring revenue
business model. InnerScope Hearing Technologies Inc.
(OTCPNK:
INND) expects to benefit now that the FDA has released
the "Final Rule" creating a new category of Over-the-Counter
hearing aids for perceived mild to moderate hearing losses to be
sold directly to consumers in retail stores, pharmacies and online
without a medical exam or being fitted by a hearing healthcare
professional. InnerScope, with its Network of Wholesale Retailers,
believes it is well-positioned and poised to take be the leader in
the new emerging OTC hearing aid market.
How will the WINR deal impact current stakeholders and what
advantages will INND have in the OTC hearing aid market? READ
MORE
Copy and paste to browser may be required https://tradersnewssource.com/tns-reports-new-developments/
Last week American Virtual Cloud Technologies, Inc.
(NASDAQ:
AVCT) announced that it intends to affect a 1-for-15
reverse stock split of its issued and outstanding shares of common
stock. The company's common stock is expected to begin trading on a
split-adjusted basis when the market opens on October 3, 2022. AVCT
operates under the Kandy brand name and operates cloud-based
communications marketplaces for telecom carriers. Anavex
Life Sciences Corp. (NASDAQ:
AVXL) recently announced that the USPTO issued a
patent to Anavex, with claims to treatment methods using its
leading drug candidate, ANAVEX®2-73. The company believes that
their drug candidate could treat disorders, including but not
limited to, Rett syndrome, Angelman syndrome, Williams syndrome,
cerebral palsy, autism spectrum disorder, and multiple
sclerosis.
How will the AVCT reverse split impact the company and does AVXL
have a blockbuster drug candidate in ANAVEX®2-73? READ
MORE
Copy and paste to browser may be required https://tradersnewssource.com/tns-reports-new-developments/
DISCLOSURE
Traders News Source LLC (TNS) produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering small and micro-cap equity markets.
TNS has two distinct and independent departments. One department
produces non-sponsored analyst certified content generally in the
form of press releases, articles and reports covering equities
listed on NYSE, NASDAQ, and OTC exchanges. The other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
PRESS RELEASE PROCEDURES
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a
third-party research service company (the "Reviewer") represented
by a chartered financial analyst, for further information on
analyst credentials, please email editor@tradersnewssource.com. TNS
LLC provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on publicly available information which is
believed to be reliable. Content is researched, written, and
reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author per
the procedures outlined by TNS. TNS is not entitled to veto or
interfere in the application of such procedures by the third-party
research service company to the articles, documents, or reports.
Unless otherwise noted, any content outside of this document has no
association with the Author or the Reviewer in any way.
NO WARRANTY
TNS, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake, or shortcoming. No liability is
accepted whatsoever for any direct, indirect, or consequential loss
arising from the use of this document. TNS, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, TNS, the Author, and the Reviewer do not (1)
guarantee the accuracy, timeliness, completeness, or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither TNS nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit https://tradersnewssource.com/near-term-catalysts/.
For any questions, inquiries, or comments reach out to us
directly. If you're a company we are covering and wish to no longer
be featured on our coverage list, contact us via email at:
editor@tradersnewssource.com
Media Contact
Mark Roberts editor@tradersnewssource.com
SOURCE: Traders News Source
Innerscope Hearing Techn... (PK) (USOTC:INND)
Historical Stock Chart
From Oct 2024 to Nov 2024
Innerscope Hearing Techn... (PK) (USOTC:INND)
Historical Stock Chart
From Nov 2023 to Nov 2024
